Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DATA LICENSE AGREEMENT between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and uniQure biopharma B.V. for AAV2.GDNF DataData License Agreement • January 2nd, 2014 • uniQure B.V. • Pharmaceutical preparations • California
Contract Type FiledJanuary 2nd, 2014 Company Industry JurisdictionThis license agreement (“Agreement”) is made effective this 12th day of June, 2012 (“Effective Date”), by and between The Regents of the University of California, a California corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 (“The Regents”), acting through its Office of Technology Management, University of California, San Francisco, 185 Berry Street Suite 4603, San Francisco, California, 94107 (“UCSF”) and uniQure biopharma B.V. (uniQure) a Netherlands corporation, having a principal place of business at Meibergdreef 61, 1105 BA Amsterdam, the Netherlands (“Licensee”). The Regents and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DATA LICENSE AGREEMENT between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and uniQure biopharma B.V. for AAV2.GDNF DataData License Agreement • November 8th, 2013 • uniQure B.V. • Pharmaceutical preparations • California
Contract Type FiledNovember 8th, 2013 Company Industry JurisdictionThis license agreement (“Agreement”) is made effective this 12th day of June, 2012 (“Effective Date”), by and between The Regents of the University of California, a California corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 (“The Regents”), acting through its Office of Technology Management, University of California, San Francisco, 185 Berry Street Suite 4603, San Francisco, California, 94107 (“UCSF”) and uniQure biopharma B.V. (uniQure) a Netherlands corporation, having a principal place of business at Meibergdreef 61, 1105 BA Amsterdam, the Netherlands (“Licensee”). The Regents and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.